Editorial: Measurable residual disease in hematologic malignancies

Francesco Buccisano; Raffaele Palmieri; Monica L Guzman; Sara Galimberti

doi:10.3389/fonc.2023.1204393

Editorial: Measurable residual disease in hematologic malignancies

Front Oncol. 2023 May 10:13:1204393. doi: 10.3389/fonc.2023.1204393. eCollection 2023.

Authors

Francesco Buccisano¹, Raffaele Palmieri¹, Monica L Guzman², Sara Galimberti³

Affiliations

¹ Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
² Weill Cornell Medicine, Cornell University, White Plains, NY, United States.
³ Division of Hematology, University Hospital of Pisa, Pisa, Italy.

No abstract available

Keywords: MRD - measurable residual disease; chimerism after allo-HSCT; multiparameter flow cytometry; next generation flow cytometry (NGF); next generation sequencing; polymerase chain reaction; surrogate endpoint biomarker.

Publication types

Editorial